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Background: Crataeva nurvala Buch.-Ham. (Family: Capparidaceae) is widely used as anti-inflammatory,
contraceptive, laxative, lithotropic, febrifuge and as tonic in traditional medicine. This study evaluated the
antinociceptive effect of the methanolic extract of the leaves of Crataeva nurvala (MECN).
Methods: The antinociceptive activity was investigated using heat-induced (hot-plate and tail-immersion test)
and chemical-induced (acetic acid, formalin and glutamic acid) nociception models in mice at different doses
(50, 100, and 200 mg/kg, p.o.) of MECN. Morphine sulphate (5 mg/kg, i.p.) and diclofenac sodium (10 mg/kg,
i. p.) were used as reference analgesic drugs.
Results: MECN produced significant dose-dependent antinociception when assessed using hot plate test, tail
immersion test and acetic acid-induced abdominal writhing test (65.55%). Likewise, MECN at similar doses
produced significant dose-dependent inhibition in both neurogenic (50.82%) and inflammatory pain (73.53%)
induced by intraplantar injection of formalin (2.5% formalin, 20 μl/paw). Besides, MECN also significantly inhibited
the glutamate-induced (10 μM/paw) pain in mice (74.68%). It was demonstrated that pretreatment with naloxone
(2 mg/kg, i.p.) significantly reversed antinociception produced by MECN in hot plate and tail immersion test
suggesting the involvement of opioid receptor. In addition, administration of glibenclamide (10 mg/kg, i.p.), an
ATP-sensitive K+ channel antagonist could not reverse antinociceptive activity induced by MECN.
Conclusion: The results suggest that MECN possesses antinociceptive activity involving inhibition of opioid system
as well as the glutamatergic system supporting its traditional uses.
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Crataeva nurvala Buch.-Ham., a common plant in
Bangladesh locally known as Borun or Bonna, is a
medium sized branched deciduous tree which grows
throughout the bank of rivers, canals, lakes and roadsides
of tropical, and sub-tropical countries of the world [1].
For a long period of time this plant has been used in the
traditional medicine of Bangladesh as anti-inflammatory,
contraceptive, laxative, lithotropic, febrifuge and tonic. It
is also useful in the treatment of kidney stone, bladder
stone, vomiting, gastric irritation and rheumatic fever [2].
Besides, C. nurvala is used to treat waste elimination and
breathing problems, metabolic disorders, joint lubrication,
skin moisture, wound healing, memory loss, heart and* Correspondence: zafarimam@gmail.com
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article, unless otherwise stated.lung weakness and weak immune system. The bark is
also used in Unani system as appetite promoter and to
decrease bile and phlegm secretion [3]. Preliminary
phytochemical screening revealed that the leaves contain
L-stachydrine, dodecanoic anhydride, methyl pentaco-
sanoate, kaemferol-O-α-D-glucoside and quercitin-3-
O-α-D-glucoside16 [4]. The stem bark, fruit and root
contain saponins, flavonoids, sterols and glucosilinates,
friedelin, cadabicine diacetate, lupeol, betulinic acid
and diosgenin, glucocapparin, triacontane, triaconta-
nol, cetyl and ceryl alcohol, pentadecane, octanamide,
12-tricosanone and friedelin, rutin, quercitin, varunol
and β-sitosterol [5]. It was reported that, the com-
pound lupeol isolated from C. nurvala stem bark and
its ester lupeol linoleate have shown anti-inflammatory
activity in complete Freund’s adjuvant induced arthritic
rats [6]. Lupeol also increased glutathione and catalaseMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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erties [7]. Besides, the extract from the stem bark
also showed antidiabetic activity in alloxan-induced
diabetic rats [8].
To our best knowledge, there is no report about the
antinociceptive activity of C. nurvala leaves. So the metha-
nolic extract of C. nurvala leaves was investigated for it’s
potential antinociceptive activity in different experimental
models in mice.
Methods
Plant material and extraction
The leaves of C. nurvala were collected from the road
side plants naturally grown at Muradnagar in Comilla
district of Bangladesh in October 2012. The collected
samples were identified by Bushra Khan, Principal
Scientific Officer, Bangladesh National Herbarium,
Mirpur, Dhaka, Bangladesh. A voucher specimen (DACB:
37942) has been deposited in the Herbarium for further
reference. Powdered dried leaves (250 g) were macer-
ated with 500 ml of methanol with occasional stirring
at 25 ± 2°C for 3 days. The extract was then filtered
using a Buchner funnel and a sterilized cotton filter.
The solvent was completely removed by rotary evapor-
ator and 10.31 g extract (yield 4.12%) was obtained.
This crude extract was used for the acute toxicity and
antinociceptive activity studies.
Animals
Swiss albino mice (20–25 g) were collected from Animal
Resources Branch of the International Center for Diarrheal
Disease Research, Bangladesh (icddr,b). The animals
were kept in standard laboratory conditions (relative
humidity 55-60%; room temperature 25 ± 2°C; 12 h
light/dark cycle) and were provided with standard diet
(icddr,b formulated) and clean water ad libitum during
acclimatization period. The animals were acclimatized
to the laboratory environment for a period of 14 days
prior performing the experiments. The animals were
fasted overnight before the experiments. All the ex-
perimental animals were treated following the Ethical
Principles and Guidelines for Scientific Experiments
on Animals (1995) formulated by The Swiss Academy
of Medical Sciences and the Swiss Academy of Sciences.
All experimental protocols were approved by the Ethics
Committee of Stamford University Bangladesh (SUB/
IAEC/12.03).
Drugs and treatments
The standard drug morphine sulphate (5 mg/kg) used in
hot plate and tail immersion tests and diclofenac sodium
(10 mg/kg) in writhing and licking tests were adminis-
tered intraperitoneally 15 min before the experiments
while the animals in control group received vehicle(DMSO : H2O in 2:1 ratio) orally at the dose of 10 ml/ kg
body weight 30 min before the experiments. MECN
was dissolved in DMSO and H2O in 2:1 ratio respect-
ively and orally administered to the test animals
30 min before the experiments at the doses of 50, 100,
and 200 mg/kg body weight in both the chemical- and
heat-induced pain models. Naloxone, a non-selective
opioid receptor antagonist, was injected intraperitone-
ally at 2 mg/kg dose 15 min before the administration
of morphine sulphate or MECN (50, 100, and 200 mg/kg)
to investigate the involvement of opioid receptor sys-
tem. Besides, an ATP-sensitive K+ channel inhibitor,
glibenclamide (10 mg/kg) was also injected intraperito-
neally to verify the involvement of ATP-sensitive K+
channel pathway.
Acute toxicity test
The test animals were divided into control and three test
groups each containing five animals. MECN was adminis-
tered p.o. at the doses of 1,000 2,000 and 3,000 mg/kg.
The mice were allowed food and water ad libitum and all
animals were observed for toxic symptoms and mortality
for the next 72 h [9].
Antinociceptive analysis
Hot plate test
The mice that showed forepaw licking, withdrawal of
the paw(s) or jumping response within 15 s on hot
plate kept at a temperature of 50 ± 0.5°C were selected
for this study 24 h prior to the experiment. Mice were
fasted overnight with water given ad libitum. The
animals were treated with morphine or extract and
were placed on Eddy’s hot plate kept at a temperature
of 50 ± 0.5°C. A cut off period of 20 s was maintained
to avoid paw tissue damage [10]. The response in the
form of forepaw licking, withdrawal of the paw(s) or
jumping was recorded at 30, 60, 90, and 120 min fol-
lowing the treatment. Then the % MPE was calculated
from the latency periods.
Tail immersion test
To evaluate the central analgesic property the tail
immersion test was performed. This procedure is based
on the observation that morphine like drugs prolongs
the tail withdrawal time from hot water in mice [11].
One to two cm of tail of the mice pretreated with
morphine or MECN were immersed in warm water
kept constant at 54 ± 0.5°C. The latency between tail
immersion and deflection of tail was recorded. A la-
tency period of 20 s was maintained to avoid tail tissue
damage in mice. The latency period of the tail-
withdrawal response was taken as the index of antino-
ciception and was determined at 30, 60, 90, and
120 min after the administration of the drug and
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periods.
Acetic acid-induced writhing test
In this test, the mice were treated with drug or extract
and then the writhing was induced by injecting 0.6%
acetic acid after 15 and 30 min, respectively, at the dose
10 ml/kg body weight. After five minutes the mice were
observed and the number of writhing was counted for
30 min [12]. The contractions of the abdomen, elong-
ation of the body, twisting of the trunk and/or pelvis
ending with the extension of the limbs were considered
as complete writhing.
Formalin-induced nociception
Mice were injected with 20 μl of 2.5% formalin solution
(equivalent to 0.92% formaldehyde) made up in saline,
into the sub-plantar region of the right hind paw 60 min
after MECN treatment and 15 min after injection of
Diclofenac sodium. Licking of the injected paw was re-
corded as nociceptive response at 0–5 min (neurogenic
phase) and 15–30 min (inflammatory phase) after forma-
lin injection [13,14].
Glutamate-induced nociception
20 μL of glutamate (10 μM/paw) was injected into the
ventral surface of the right hind paw of the mice 30 min
after MECN treatment and 15 min after injection of
Diclofenac sodium. The mice were observed for 15 min
following glutamate injection. The number of licking of




Control 0.1 ml/mouse 5.87 ± 0.20 6.30 ± 0.13
Morphine 5 6.67 ± 0.30 12.70 ± 0.51* (45.2
MECN 50 5.72 ± 0.74 7.84 ± 0.63 (14.90)
MECN 100 6.71 ± 0.48 8.98 ± 0.56** (17.0
MECN 200 5.83 ± 0.66 9.54 ± 0.21* (26.22
NLX 2 7.22 ± 0.34 7.05 ± 0.18
NLX + Control 2 + 0.1 ml/mouse 5.93 ± 0.27 6.15 ± 0.10
NLX + Morphine 2 + 5 6.41 ± 0.37 7.25 ± 0.40a (6.24)
NLX + MECN 2 + 50 5.98 ± 0.61 6.31 ± 0.38 (2.37)
NLX + MECN 2 + 100 5.95 ± 0.81 6.49 ± 0.76b (3.80)
NLX + MECN 2 + 200 6.18 ± 0.96 7.04 ± 0.41c (6.25)
Each value is presented as the mean ± SEM (n = 5). MECN =Methanolic extract of. C
*p < 0.001 compared with the control group (Dunnett’s test).
**p < 0.01 compared with the control group (Dunnett’s test).
ap < 0.001 compared with the morphine group (Bonferroni’s test).
bp < 0.05 compared with the MECN 100 group (Bonferroni’s test).
cp < 0.05 compared with the MECN 200 group (Bonferroni’s test).Analysis of the possible mechanism of action of MECN
Involvement of opioid system
The possible participation of the opioid system in the
antinociceptive effect of MECN was examined by inject-
ing naloxone hydrochloride (2 mg/kg i.p.), a non-
selective opioid receptor antagonist, 15 min prior to the
administration of either morphine or MECN. Then the
hot plate and tail immersion latencies were sequen-
tially measured at pretreatment, 30, 60, 90 and
120 min with the same cut off time of 20 s for the
safety of animals [16].
Involvement of ATP-sensitive K+ channel pathway
Possible contribution of K+ channel in the antinocicep-
tive effect of MECN was evaluated by using the method
described previously [17,18]. The mice were pretreated
with glibenclamide (10 mg/kg), an ATP-sensitive K+
channel inhibitor, intraperitonially 15 min before ad-
ministration of either diclofenac sodium or MECN.
The mice were challenged with i.p. injection of 0.6%
acetic acid, 30 min post-treatment. Following the in-
jection of acetic acid, the animals were immediately
placed in a chamber and the number of writhing
was recorded for 30 min, starting from 5 min post
injection.
Statistical analysis
The results are presented as Mean ± SEM. The statistical
analysis was performed using one way analysis of
variance (ANOVA) followed by Dunnett’s post hoc
test or Bonferroni’s test as appropriate useing SPSSvala leaves, morphine, and reversal effect of naloxone in
Response time (s) (%MPE)
60 min 90 min 120 min
6.72 ± 0.09 8.62 ± 0.32 9.34 ± 0.25
3) 14.75 ± 1.03* (60.64) 15.70 ± 0.86* (67.77) 15.84 ± 0.94 (68.82)
8.31 ± 0.43 (18.17) 10.19 ± 0.60 (31.35) 10.37 ± 0.51 (32.58)
4) 9.66 ± 0.12** (22.16) 13.16 ± 0.89** (48.52) 13.06 ± 1.66 (47.73)
) 11.74 ± 0.72* (41.70) 13.86 ± 1.12* (56.69) 13.71 ± 1.78 (55.60)
6.85 ± 0.13 6.71 ± 0.29 5.30 ± 0.36
6.54 ± 0.19 8.01 ± 0.37 8.38 ± 0.69
7.65 ± 0.16a (9.15) 8.86 ± 0.26a (18.02) 8.96 ± 0.19a (18.82)
7.41 ± 0.22 (10.17) 9.13 ± 0.79 (22.44) 9.71 ± 0.46 (26.59)
7.93 ± 0.46 (14.05) 9.53 ± 0.61 (25.49) 10.08 ± 1.00 (29.36)
8.75 ± 1.02c (18.64) 9.95 ± 1.33c (27.30) 10.14 ± 0.59 (28.69)
rataeva nurvala leaves; NLX = Naloxone.
Table 2 Antinociceptive effect of methanolic extract of C. nurvala leaves, morphine, and reversal effect of naloxone in
tail immersion test
Treatment Dose(mg/kg) Response times (s) (%MPE)
Pretreatment 30 min 60 min 90 min 120 min
Control 0.1 ml/mouse 1.78 ± 0.17 2.01 ± 0.19 2.44 ± 0.09 2.77 ± 0.30 2.93 ± 0.29
Morphine 5 1.62 ± 0.10 3.11 ± 0.37* (8.13) 3.95 ± 0.27* (12.66) 4.35 ± 0.28* (14.87) 4.17 ± 0.24 (13.88)
MECN 50 1.75 ± 0.11 2.13 ± 0.11 (2.13) 2.32 ± 0.04 (3.16) 2.79 ± 0.19 (5.70) 2.96 ± 0.06 (6.67)
MECN 100 1.91 ± 0.13 2.63 ± 0.33 (3.98) 3.06 ± 0.53 (6.36) 4.15 ± 0.59* (12.37) 4.28 ± 0.59* (13.08)
MECN 200 1.81 ± 0.14 3.03 ± 0.26* (6.67) 3.75 ± 0.17* (10.66) 4.26 ± 0.34* (13.46) 4.58 ± 0.26* (15.20)
NLX 2 1.91 ± 0.11 2.23 ± 0.17 2.29 ± 0.19 2.30 ± 0.17 2.22 ± 0.32
NLX + Control 2 + 0.1 ml/mouse 1.68 ± 0.15 1.97 ± 0.08 2.11 ± 0.10 2.14 ± 0.13 2.27 ± 0.16
NLX + Morphine 2 + 5 1.94 ± 0.18 2.08 ± 0.08 (0.80) 2.52 ± 0.05a (3.26) 2.95 ± 0.14a (5.64) 3.11 ± 0.11 (6.50)
NLX + MECN 2 + 50 1.91 ± 0.16 2.08 ± 0.07 (0.94) 2.11 ± 0.08 (1.12) 2.13 ± 0.32 (1.22) 2.20 ± 0.38 (1.61)
NLX + MECN 2 + 100 1.78 ± 0.11 2.10 ± 0.13 (1.75) 2.21 ± 0.11 (2.38) 2.32 ± 0.04b (2.99) 2.71 ± 0.15 (5.12)
NLX + MECN 2 + 200 1.95 ± 0.11 2.20 ± 1.10 (1.38) 2.41 ± 0.14c (2.56) 2.55 ± 0.07c (3.33) 2.80 ± 0.06c (4.69)
Each value is presented as the mean ± SEM (n = 5). MECN =Methanolic extract of. Crataeva nurvala leaves; NLX = Naloxone.
*p < 0.05 compared with the control group (Dunnett’s test).
ap < 0.05 compared with the morphine group (Bonferroni’s test).
bp < 0.05 compared with the MECN 100 group (Bonferroni’s test).
cp < 0.01 compared with the MECN 200 group (Bonferroni’s test).
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The results of the tail immersion and hot plate tests were
given with percentage of the maximal possible effect
(%MPE), which was calculated as follows:
% MPE ¼  postdrug latencyð Þ − predrug latencyð Þ = cutoff timeð Þ
− predrug latencyð Þ  100
Results and discussion
Acute toxicity test
The present study demonstrated that oral administration
of the MECN at the doses of 1,000 2,000 and 3,000 mg/kg
did not show any mortality, behavioral changes (sedation,
excitability) or allergic manifestations during the 72 h
observation period after administration. Therefore, it can
be assumed that MECN possess low toxicity profile and







Values are expressed as Mean ± SEM (n = 5); * denotes p < 0.001 compared with cHot plate and tail immersion tests
The hot plate and tail immersion methods are useful for
the evaluation of centrally acting analgesics which are
known to elevate the pain threshold of mice towards
heat [19]. These tests are useful to determine the in-
volvement of the opioid receptors in the action of the
narcotic drugs or other analgesic agents that give effect
in this pathway [20]. In our study we have found the
maximum effects of the MECN at all doses reached at
30–90 min (Tables 1 and 2). In both heat-induced
methods MECN particularly at 100 and 200 mg/kg
doses significantly prolonged the latency period ( P < 0.05).
The ability of the extract to prolong the reaction latency
suggests that the extract is endowed with central analgesic
activity.
Acetic acid writhing test
The acetic acid induced writhing test is widely used for
antinociceptive screening and involves local peritonealuced abdominal writhing test in mice
Responses
Number of writhing (Mean ± SEM) % Inhibition
65.90 ± 2.05 -
20.00 ± 0.79* 69.65
59.10 ± 3.74 10.32
32.20 ± 1.41* 51.14
22.70 ± 0.91* 65.55
ontrol group (Dunnett’s test).
Table 4 Antinociceptive effect of methanolic extract of C. nurvala leaf in formalin test in mice
Treatment Dose (mg/kg) Licking number % Inhibition
(Mean ± SEM)
Early phase Late phase Early phase Late phase
Control 0.1 ml/mouse 143.20 ± 2.11 149.60 ± 3.61 - -
Diclofenac sodium 10 mg/kg 28.40 ± 1.36* 7.40 ± 0.51* 80.17 95.05
MECN 50 mg/kg 126.60 ± 7.52 87.40 ± 4.50* 11.59 41.58
MECN 100 mg/kg 111.40 ± 4.58* 50.20 ± 2.44* 22.21 66.44
MECN 200 mg/kg 71.20 ± 0.97* 39.60 ± 2.89* 50.28 73.53
Values are expressed as Mean ± SEM (n = 5); * denotes p < 0.001 compared with control group (Dunnett’s test).
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as the mediators of acetylcholine and histamine [21].
In the abdominal tissues acetic acid injection produces
peritoneal inflammation, which triggers a response
characterized by writhing [22]. Such types of responses
are induced by the release of endogenous mediators of
pain such as prostaglandins, bradykinine and cytokines
(TNF-α, IL-1β and IL-8) that stimulate the nociceptive
neurons, which are sensitive to non steroidal anti-
inflammatory drugs (NSAIDs) and opioids [23]. In our
study, MECN inhibitied the acetic acid induced writh-
ing in a dose dependent manner. MECN at the dose of
200 mg/kg and 100 mg/kg displayed the highest signifi-
cant (P < 0.001) inhibition of writhing (65.55% and
51.14%) that are comparable to the antinociceptive
activity of diclofenac sodium (69.65%) (Table 3). These
responses can be described as a typical model of
inflammatory pain in which the sensory neurons are
depolarized by directly activating a non-selective cationic
channel of cutaneous, visceral and other types of periph-
eral afferent C fibers [24]. Thus, the significant reduction
in the number of acetic acid-induced writings by MECN
indicates the antinociceptive potential of this plant and
confirms its traditional use for the relief of inflammatory
pain.
Formalin induced nociception
In formalin test, intraplantar injection of formalin com-







Values are expressed as Mean ± SEM (n = 5); * denotes p < 0.001 compared with cthe neurogenic pain is caused by direct activation of type
C nociceptive nerve endings, releasing neuropeptides
such as substance P, among others. On the other hand,
the second phase is characterized as inflammatory pain,
related to the release of chemical mediators such as
histamine, serotonin, bradykinin, prostaglandins and
excitatory amino acids, which can be inhibited by pain-
killers and anti-inflammatory drugs [25-27]. In our
study, MECN produced antinociception in both phases
of the formalin test, although the effect was more pro-
nounced in the inflammatory phase (Table 4). Therefore,
it is reasonable that it has the same antinociceptive activity
as central analgesic drugs. Moreover, the antinociceptive
effect of MECN on the later phase suggested the antino-
ciceptive potential could involve the anti-inflamatory
property.
Glutamate induced nociception
In addition, to investigate the involvement of glutamater-
gic receptors in this antinociception, we used L-glutamic
acid to produce nociception. We found that, MECN sig-
nificantly inhibited the noxious stimuli by L-glutamic
acid in a dose dependent manner. These inhibitions are
comparable to the reference drug diclofenac sodium,
which produces 68.45% inhibition of the pain (Table 5).
The 200 mg/kg produced 74.68% inhibition of the noci-
ception that is higher than the effect produced by the
reference drug. Thus it can be assumed that the MECN
inhibited the excitatory amino acids, PGE2 (Prostaglandinamate-induced nociception in mice
Responses
Number of licking (Mean ± SEM) % Inhibition
157.20 ± 4.87 0
49.60 ± 1.08* 68.45
59.60 ± 2.25* 62.09
49.00 ± 2.39* 68.83
39.80 ± 3.53* 74.68
ontrol group (Dunnett’s test).
Table 6 Effect of methanolic extract of C. nurvala leaf on Involvement of ATP-sensitive K+ channel pathway
Treatment Dose (mg/kg) Responses
Number of writhing (Mean ± SEM) % Inhibition
Control 0.1 ml/mouse 73.90 ± 1.61 -
Diclofenac sodium 10 19.90 ± 0.53* 73.07
MECN 50 54.70 ± 1.83* 25.98
MECN 100 29.90 ± 0.66* 59.54
MECN 200 18.30 ± 1.25* 75.24
Glib 10 75.1 ± 2.01 −1.62
Glib + Diclofenac-sodium 10 + 10 36.20 ± 1.77a 51.05
Glib + MECN 10 + 50 50.00 ± 1.53 32.34
Glib + MECN 10 + 100 28.00 ± 2.13 62.11
Glib + MECN 10 + 200 20.00 ± 1.34 72.94
Each value is presented as the Mean ± SEM (n = 5). MECN =Methanolic extract of. Crataeva nurvala leaves; Glib = Glibenclemide.
*p < 0.001 compared with the control group (Dunnett’s test).
ap < 0.001 compared with the Diclofenac sodium treated group (Bonferroni’s test).
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released by the glutamate and more glutamate in the dorsal
horn. MECN may be blocked the NMDA (N-methyl- D-
aspartate) and non-NMDA receptors as well as inhibiting
the release of NO or some NO-related substances that are
present in peripheral, spinal and supraspinal sites of action
[15,28].
Involvement of opioid system and ATP-sensitive K+ channel
pathway
To further investigate the participation of opioid receptor
system we investigated the effect of naloxone (a non-
selective opioid receptor antagonist) against the analgesic
activity of MECN in both the hot plate and tail immersion
tests. The data obtained showed that the analgesic effect
produced by MECN was reversed by naloxone. It was
reported that both in tail-immersion and hot-plate tests
thermal stimuli influenced the spinal (through μ2 and δ
opioid receptors) and the supraspinal (through μ1/μ2-
opioid receptors) reflex respectively [29,30]. Since nalox-
one succeeds to antagonize the analgesic activity, thus
the analgesic activity of MECN seems to be related to
opioid receptor. On the other hand, glibenclamide, an
ATP sensitive K+ channel blocker did not significantly
alter the antinociceptive effect of the extract (Table 6),
it is speculated that the antinociceptive mechanism
may not involve with the opening of ATP sensitive K+
channel pathway.
Conclusion
The results of the present study indicates that MECN
exhibited significant antinociceptvie activity at all the
tested doses in mice. The effect is dose dependent and
statistically significant particulary at 100 and 200 mg/kg
doses. The reversal effect by naloxone indicates theinvolvement of opioid and glutamate pathway in the
antinociceptive effect of MECN. This indicates the
presence of analgesic phytochemical(s) in the plant extract.
Further studies are required to carry out antinociceptive
activity test using isolated pure compound.
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